| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/01/2014 | CN103479976A Prescription for treating common cold due to wind cold |
| 01/01/2014 | CN103479969A Medicine for treating manic-depressive psychosis and preparation method thereof |
| 01/01/2014 | CN103479961A Insomnia treatment traditional Chinese medicine |
| 01/01/2014 | CN103479959A Traditional Chinese medicine for treating senile dementia |
| 01/01/2014 | CN103479911A Chinese herbal composition for treating stroke sequelae |
| 01/01/2014 | CN103479904A Traditional Chinese medicine composition for treating mental disease |
| 01/01/2014 | CN103479900A Traditional Chinese medicine used for treating athetosis |
| 01/01/2014 | CN103479899A Insomnia treatment traditional Chinese medicine composition |
| 01/01/2014 | CN103479880A Chinese herbal composition for treating neurasthenia |
| 01/01/2014 | CN103479855A Preparation method of Chinese materia medica preparation for treating senile dementia |
| 01/01/2014 | CN103479826A Traditional Chinese medicine composition for treating migraine |
| 01/01/2014 | CN103479825A Traditional Chinese medicine for treatment of migraine |
| 01/01/2014 | CN103479807A Brain protecting composition as well as preparation method and application thereof |
| 01/01/2014 | CN103479800A Traditional Chinese medicine for treating sciatica |
| 01/01/2014 | CN103479799A Trigeminal neuralgia treatment traditional Chinese medicine composition |
| 01/01/2014 | CN103479783A Chinese medicine composite for curing climacteric melancholia and application thereof |
| 01/01/2014 | CN103479780A Traditional Chinese medicine composition for treating senile dementia |
| 01/01/2014 | CN103479778A Pharmaceutical composition for preventing birth defects and improving memory |
| 01/01/2014 | CN103479766A Compound essential oil for relieving aloneness |
| 01/01/2014 | CN103479757A Compound essential oil relieving insecurity |
| 01/01/2014 | CN103479743A Pharmaceutical composition for treating senile dementia and preparation method thereof |
| 01/01/2014 | CN103479742A Traditional Chinese medicine for treating trigeminal neuralgia |
| 01/01/2014 | CN103479739A Pharmaceutical composition for preventing birth defects and improving memory |
| 01/01/2014 | CN103479705A Composition for counteracting smoking toxicity |
| 01/01/2014 | CN103479684A Pharmaceutical composition for preventing birth defects and improving memory |
| 01/01/2014 | CN103479654A Boron-containing small molecules as anti-inflammatory agents |
| 01/01/2014 | CN103479650A Application of Phyllanthoid A to in preparation of antidepressant |
| 01/01/2014 | CN103479640A New application of morphinan quaternary ammonium salt derivative |
| 01/01/2014 | CN103479639A Application of morphinan quaternary ammonium salt derivative to blocking exogenous opioids |
| 01/01/2014 | CN103479638A Sofinicline (abt-894 ) for attention-deficit/hyperactivity disorder |
| 01/01/2014 | CN103479626A Application of Fluevirosines A in preparation of Alzheimer's disease treatment medicines |
| 01/01/2014 | CN103479623A New application of double-daphne papyracea element of coumarins compounds |
| 01/01/2014 | CN103479614A Application of Spirooliganones B in preparation of medicines treating Alzheimer's disease |
| 01/01/2014 | CN103479612A Pharmaceutical application of nafamostat |
| 01/01/2014 | CN103479606A Application of selenomethionine in preparation of medicine for treating Alzheimer's disease |
| 01/01/2014 | CN103479603A Method of reducing neuronal cell damage |
| 01/01/2014 | CN103479602A Application of hydroxylamine derivatives in neural degenerative disorder treatment |
| 01/01/2014 | CN103479591A Phenytoin sodium dropping pill and preparation method thereof |
| 01/01/2014 | CN103479580A Meclofenoxate hydrochloride dry suspension and preparation method thereof |
| 01/01/2014 | CN103479526A Mineral spring powder |
| 01/01/2014 | CN103478549A Whole-grain full-nutrition formula food for epileptic consumption |
| 01/01/2014 | CN102813888B Chinese herbal composition for treating epilepsy |
| 01/01/2014 | CN102688335B Chinese medicine composition for treating wind-heat type common cold and preparation method of Chinese medicine composition |
| 01/01/2014 | CN102370754B Traditional Chinese medicine preparation for treating headache due to deficiency of blood |
| 01/01/2014 | CN102066376B Anhydrous crystal form of orvepitant maleate |
| 01/01/2014 | CN102036987B Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof |
| 01/01/2014 | CN101001646B Stabilized synthetic immunogen delivery system |
| 12/31/2013 | US8618148 Use of telmisartan for the prevention and treatment of vascular headache |
| 12/31/2013 | US8618141 Aryl ureas with angiogenesis inhibiting activity |
| 12/31/2013 | US8618130 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 12/31/2013 | US8618116 Deuterium-enriched pyrimidine compounds and derivatives |
| 12/31/2013 | US8618115 Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them |
| 12/31/2013 | US8618097 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 12/31/2013 | US8618045 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
| 12/31/2013 | US8617598 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 12/31/2013 | US8617587 Tasted masked veterinary solid compositions |
| 12/31/2013 | US8617573 Botulinum neurotoxin B receptors and use thereof |
| 12/31/2013 | US8617539 Method of administration of platelet-rich plasma to treat an acute cardiac dysfunction |
| 12/31/2013 | US8617530 Polymer conjugates of opioid antagonists |
| 12/31/2013 | CA2742833C Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 12/31/2013 | CA2666246C Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 12/31/2013 | CA2647116C Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands |
| 12/31/2013 | CA2645756C Malonamide derivatives as gamma secretase inhibitors |
| 12/31/2013 | CA2635313C Triple combination release multi-layered tablet |
| 12/31/2013 | CA2629018C Aza-substituted spiro derivative |
| 12/31/2013 | CA2613192C Histamine h3 receptor agents, preparation and therapeutic uses |
| 12/31/2013 | CA2599974C Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 12/31/2013 | CA2599291C Compounds for reducing aggregation of amyloid beta-peptide |
| 12/31/2013 | CA2554728C Production method of nicotine transdermal preparation |
| 12/31/2013 | CA2527145C Use of iron for treating attention deficit hyperactivity disorder in children |
| 12/31/2013 | CA2426030C Methods of treating disorders related to apoe |
| 12/27/2013 | WO2013192493A1 Nanoparticles of indirubin, derivatives thereof and methods of making and using same |
| 12/27/2013 | WO2013192306A1 Positive allosteric modulators of mglur2 |
| 12/27/2013 | WO2013192273A1 Heteroaryl compounds and methods of use thereof |
| 12/27/2013 | WO2013192229A1 Substituted pyridine azolopyrimidine - 5 - (6h) - one compounds |
| 12/27/2013 | WO2013192225A1 Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds |
| 12/27/2013 | WO2013192163A1 Gluten-related disorders |
| 12/27/2013 | WO2013191509A1 Pharmaceutical composition for preventing and treating parkinson's disease, containing n-terminal truncated ubiquitin c-terminal hydrolase-l1 (nt-uch-l1) as active ingredient |
| 12/27/2013 | WO2013191244A1 Pyridopyrimidin-4-one derivative |
| 12/27/2013 | WO2013191236A1 Composition for improving and/or treating central nervous system degenerative disease |
| 12/27/2013 | WO2013191144A1 Novel indanesulfamide derivative |
| 12/27/2013 | WO2013191128A1 Skin patch |
| 12/27/2013 | WO2013190325A1 Thymidine for preventing neural tube defects |
| 12/27/2013 | WO2013190302A1 Camsylate salt |
| 12/27/2013 | WO2013190301A1 Cycloalkyl ether compounds and their use as bace inhibitors |
| 12/27/2013 | WO2013190299A1 Cyclohexane-1,2'-indene-1',2"-imidazol compounds and their use as bace inhibitors |
| 12/27/2013 | WO2013190298A1 2h-imidazol-4-amine compounds and their use as bace inhibitors |
| 12/27/2013 | WO2013190068A1 Probiotic and polyphenol against neurodegeneration |
| 12/27/2013 | WO2013188999A1 Application of inula lineariifolia lactone a in preparation of medicine for treating multiple sclerosis |
| 12/27/2013 | WO2013128276A3 Tamper resistant immediate release formulations |
| 12/27/2013 | WO2012162635A8 Metabotropic glutamate receptors 5 modulators and methods of use thereof |
| 12/27/2013 | CA2877149A1 Substituted pyridine azolopyrimidine-5-(6h)-one compounds |
| 12/27/2013 | CA2877146A1 Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds |
| 12/27/2013 | CA2877097A1 Novel indanesulfamide derivative |
| 12/27/2013 | CA2876979A1 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| 12/27/2013 | CA2876969A1 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors |
| 12/27/2013 | CA2876963A1 Gluten-related disorders |
| 12/27/2013 | CA2875589A1 Camsylate salt |
| 12/27/2013 | CA2875588A1 Cyclohexane-1,2'-indene-1',2"-imidazole compounds and their use as bace inhibitors |
| 12/27/2013 | CA2875494A1 2h-imidazol-4-amine compounds and their use as bace inhibitors |